{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:32:21Z","timestamp":1778113941875,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T00:00:00Z","timestamp":1532563200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1038\/s41443-018-0046-2","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T14:14:16Z","timestamp":1532614456000},"page":"203-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Combination therapy for erectile dysfunction involving a PDE5 inhibitor and alprostadil"],"prefix":"10.1038","volume":"30","author":[{"given":"I.","family":"Moncada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Martinez-Salamanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Ruiz-Casta\u00f1e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"46_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jsxm.2015.12.034","volume":"13","author":"MP McCabe","year":"2016","unstructured":"McCabe MP, Sharlip ID, Lewis R, Atalla E, Balon R, Fisher AD, et al. Incidence and prevalence of sexual dysfunction in women and men: A consensus statement from the fourth international consultation on sexual medicine 2015. J Sex Med. 2016;13:144\u201352.","journal-title":"J Sex Med"},{"key":"46_CR2","unstructured":"Hatzimouratidis K, Giuliano F, Moncada I, Muneer A, Salonia A, Verze P et al. European Association of Urology Guidelines on Male Sexual Dysfunction \n                    https:\/\/uroweb.org\/guideline\/male-sexual-dysfunction\n                    \n                  . Accessed November 2017, 18\u201321"},{"key":"46_CR3","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1056\/NEJM200006153422407","volume":"342","author":"TF Lue","year":"2000","unstructured":"Lue TF. Erectile dysfunction. N Engl J Med. 2000;342:1802\u201313.","journal-title":"N Engl J Med"},{"key":"46_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1517\/14656566.2014.873789","volume":"15","author":"V Hanchanale","year":"2014","unstructured":"Hanchanale V, Eadley I. Alprostadil for the treatment of impotence. Expert Opin Pharmacother. 2014;15:421\u20138.","journal-title":"Expert Opin Pharmacother"},{"key":"46_CR5","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/S0022-5347(05)68085-8","volume":"162","author":"C McMahon","year":"1999","unstructured":"McMahon C, Samali R, Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol. 1999;162:1992\u20138.","journal-title":"J Urol"},{"key":"46_CR6","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/sj.ijir.3901448","volume":"18","author":"K Nandipati","year":"2006","unstructured":"Nandipati K, Raina R, Agarwal A, Zippe CD. Early combination therapy: intracavernosal injections and sildenafil following radical prostatectomy increases sexual activity and the return of natural erections. Int J Impot Res. 2006;18:446\u201351.","journal-title":"Int J Impot Res"},{"key":"46_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/sj.ijir.3901290","volume":"17","author":"P Gutierrez","year":"2005","unstructured":"Gutierrez P, Hernandez P, Mas M. Combining programmed intracavernous PGE1 injections and sildenafil on demand to salvage sildenafil nonresponders. Int J Impot Res. 2005;17:354\u20138.","journal-title":"Int J Impot Res"},{"key":"46_CR8","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1464-410X.2005.05413.x","volume":"95","author":"JH Mydlo","year":"2005","unstructured":"Mydlo JH, Viterbo R, Crispen P. Use of combined intracorporal injection and a phosphodiesterase-5 inhibitor therapy for men with a suboptimal response to sildenafil and\/or vardenafil monotherapy after radical retropubic prostatectomy. BJU Int. 2005;95:843\u20136.","journal-title":"BJU Int"},{"key":"46_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000020248","volume":"38","author":"JH Mydlo","year":"2000","unstructured":"Mydlo JH, Volpe MA, Macchia RJ. Initial results utilizing combination therapy for patients with a suboptimal response to either alprostadil or sildenafil monotherapy. Eur Urol. 2000;38:30\u20134.","journal-title":"Eur Urol"},{"key":"46_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2164\/jandrol.05035","volume":"26","author":"R Raina","year":"2005","unstructured":"Raina R, Nandipati KC, Agarwal A, Mansour D, Kaelber DC, Zippe CD, et al. Combination therapy: medicated urethral system for erection enhances sexual satisfaction in sildenafil citrate failure following nerve-sparing radical prostatectomy. J Androl. 2005;26:757\u201360.","journal-title":"J Androl"},{"key":"46_CR11","doi-asserted-by":"publisher","first-page":"204","DOI":"10.4081\/aiua.2015.3.204","volume":"87","author":"L Labairu-Huerta","year":"2015","unstructured":"Labairu-Huerta L, Padilla-Fern\u00e1ndez B, Arrondo-Arrondo JL, Valverde-Mart\u00ednez LS, Mart\u00edn-Rodr\u00edguez A, Silva-Abu\u00edn JM, et al. PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction. Arch Ital Urol Androl. 2015;87:204\u20139.","journal-title":"Arch Ital Urol Androl"},{"issue":"Suppl 1","key":"46_CR12","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1038\/sj.ijir.3900795","volume":"14","author":"A Nehra","year":"2002","unstructured":"Nehra A, Blute ML, Barrett DM, Moreland RB. Rationale for combination therapy of intraurethral prostaglandin E(1) and sildenafil in the salvage of erectile dysfunction patients desiring noninvasive therapy. Int J Impot Res. 2002;14(Suppl 1):S38\u201342.","journal-title":"Int J Impot Res"},{"key":"46_CR13","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1111\/j.1743-6109.2008.00910.x","volume":"5","author":"I Goldstein","year":"2008","unstructured":"Goldstein I, Mulhall JP, Bushmakin AG, Cappelleri JC, Hvidsten K, Symonds T. The erection hardness score and its relationship to successful sexual intercourse. J Sex Med. 2008;5:2374\u201380.","journal-title":"J Sex Med"},{"key":"46_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/ijir.2013.8","volume":"25","author":"ST Huang","year":"2013","unstructured":"Huang ST, Jiann BP. Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction. Int J Impot Res. 2013;25:178\u201382.","journal-title":"Int J Impot Res"},{"key":"46_CR15","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/S0140-6736(82)90910-2","volume":"2","author":"R Virag","year":"1982","unstructured":"Virag R. Intracavernous injection of papaverine for erectile failure. Lancet 1982;2:938.","journal-title":"Lancet"},{"key":"46_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199701023360101","volume":"336","author":"H Padma-Nathan","year":"1997","unstructured":"Padma-Nathan H, Hellstrom WJ, Kaiser FE, Labasky RF, Lue TF, Nolten WE, et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. N Engl J Med. 1997;336:1\u20137.","journal-title":"N Engl J Med"},{"key":"46_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.5301\/uro.5000116","volume":"82","author":"I Moncada","year":"2015","unstructured":"Moncada I, Cuzin B. Clinical efficacy and safety of Vitaros\u00a9\/Virirec\u00a9 (Alprstadil cream) for the treatment of erectile dysfunction. Urologia. 2015;82:84\u201392.","journal-title":"Urologia"},{"key":"46_CR18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ijpharm.2003.09.018","volume":"271","author":"AM Wolka","year":"2004","unstructured":"Wolka AM, Rytting JH, Reed BL, Finnin BC. The interaction of the penetration enhancer DDAIP with a phospholipid model membrane. Int J Pharm. 2004;271:5\u201310.","journal-title":"Int J Pharm"},{"key":"46_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/sj.ijir.3900940","volume":"15","author":"H Padma-Nathan","year":"2003","unstructured":"Padma-Nathan H, Steidle C, Salem S, Tayse N, Yeager J, Harning R. The efficacy and safety of a topical alprostadil cream, Alprox-TD, for the treatment of erectile dysfunction: two phase 2 studies in mild-to-moderate and severe ED. Int J Impot Res. 2003;15:10\u20137.","journal-title":"Int J Impot Res"},{"issue":"2 Pt 2","key":"46_CR20","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/01.ju.0000075120.89700.9b","volume":"170","author":"WD Steers","year":"2003","unstructured":"Steers WD. Viability and safety of combination drug therapies for erectile dysfunction. J Urol. 2003;170(2 Pt 2):S20\u201323.","journal-title":"J Urol"},{"key":"46_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/sj.ijir.3901046","volume":"15","author":"CG McMahon","year":"2003","unstructured":"McMahon CG. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy. Int J Impot Res. 2003;15:383\u20134.","journal-title":"Int J Impot Res"},{"key":"46_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/sj.ijir.3900296","volume":"9","author":"KK Chew","year":"1997","unstructured":"Chew K-K, Stuckey BGA, Earle CM, Dhaliwal, Keogh EJ. Penile fibrosis in intracavernosal prostaglandin E1 injection therapy for erectile dysfunction. Int J Impot Res. 1997;9:225\u20139.","journal-title":"Int J Impot Res"},{"key":"46_CR23","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.ijir.3900853","volume":"14","author":"L Barthelmes","year":"2002","unstructured":"Barthelmes L, Chezhian C, Aihaku EK. Deep venous thrombosis and venous thrombophlebitis associated with alprostadil treatment for erectile dysfunction. Int J Impot Res. 2002;14:199\u2013200.","journal-title":"Int J Impot Res"},{"key":"46_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/sj.ijir.3901285","volume":"17","author":"J Yeager","year":"2005","unstructured":"Yeager J, Beihn RM. Retention and migration of alprostadil cream applied topically to the glans meatus for erectile dysfunction. Int J Impot Res. 2005;17:91\u20135.","journal-title":"Int J Impot Res"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0046-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0046-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:27:27Z","timestamp":1684618047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0046-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["46"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0046-2","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,26]]},"assertion":[{"value":"25 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"IM has taken part in Advisory Board meetings and also acted as a speaker for Casen Recordati and Ferring. The remaining authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}